Utility of Ga-68 DOTA PET-CT in Neuroendocrine Tumours

Radiologists

This course is designed for consultants who already have experience reporting FDG PET-CT scans and who wish to explore the role of Ga-68 DOTA PET-CT in the diagnosis and treatment of patients with neuroendocrine tumours.

Neuroendocrine tumours are a diverse group of relatively rare cancers, with a reported incidence of 9 cases per 100,000 people in 2015.

Recently there have been major advances in their diagnosis, staging and treatment.  The possibility of multiple options to investigate and treat a diverse range of rare tumours represents a challenge for all members of the MDT, not least the radiologist.

The course aims to provide an overview of the use of Ga-68 DOTA PET-CT in the diagnosis and treatment of patients with neuroendocrine tumours.

It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorial.

Suitable for radiologists and nuclear medicine physicians who intend to train to report on the utility of Ga-68 DOTA PET-CT neuroendocrine tumour imaging and molecular radiotherapy, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT.

Learning Outcomes

There are currently no defined learning outcomes for this course.

Prerequisites

This course has no prerequisites.

What Our Students Say

Learn to enjoy every minute of your life. Be happy now. Don’t wait for something outside of yourself to make you happy in the future. Think how really precious is the time you have to spend, whether it’s at work or with your family. Every minute should be enjoyed and savored.

reviewer-img

GP Participant